title: Improving maximum walking distance in early peripheral arterial disease: randomised controlled trial.
abstract: The purpose of this study was to determine the impact of increased physical activity and cessation of smoking on the natural history of early peripheral arterial disease. We conducted a randomised controlled trial in Perth, Western Australia, involving 882 men with early peripheral arterial disease identified via population-based screening using the Edinburgh Claudication Questionnaire and the ankle:brachial index. Members of the control group (n = 441) received "usual care" from their general practitioner while members of the intervention group (n = 441) were allocated to a "stop smoking and keep walking" regime - a combined community-based intervention of cessation of smoking (where applicable) and increased physical activity. Postal follow-up occurred at two and 12 months post-entry into the trial. The main outcome of interest was maximum walking distance. There were no statistically significant differences in the characteristics of the "intervention" and "usual care" groups at recruitment. Follow-up information at two and 12 months was available for 85% and 84% of participants, respectively. At 12 months, more men allocated to the intervention group had improved their maximum walking distance (23% vs 15%; chi2 = 9.74, df = 2, p = 0.008). In addition, more men in the intervention group reported walking more than three times per week for recreation (34% vs 25%, p = 0.01). Although not statistically significant, more men in the intervention group who were smokers when enrolled in the trial had stopped smoking (12% vs 8%, p = 0.43). It is concluded that referral of older patients with intermittent claudication to established physiotherapy programs in the community can increase levels of physical activity and reduce disability related to peripheral arterial disease. A combination of simple and safe interventions that are readily available in the community through physiotherapists and general practitioners has the potential to improve early peripheral arterial disease.
authors.affiliation: University of Western Australia, Australia. b.fowler@graduates.uwa.edu.au
authors.forename: Bess
authors.initials: B
authors.lastname: Fowler
authors.forename: Konrad
authors.initials: K
authors.lastname: Jamrozik
authors.forename: Paul
authors.initials: P
authors.lastname: Norman
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Allen
authors.forename: Eve
authors.initials: E
authors.lastname: Wilkinson
mesh_terms: D000203:Activities of Daily Living; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000517:prevention & control / Q000534:rehabilitation / Q000628:therapy*; D005081:Exercise Therapy / Q000379:methods; D006293:Health Promotion / Q000379:methods; D006304:Health Status; D006801:Humans; D007383:Intermittent Claudication / Q000628:therapy; D008297:Male; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000150:complications / Q000517:prevention & control / Q000534:rehabilitation / Q000628:therapy*; D011788:Quality of Life; D012307:Risk Factors; D016540:Smoking Cessation; D013997:Time Factors; D016896:Treatment Outcome; D016138:Walking; D014904:Western Australia